Anxiety and depressive disorders in patients presenting with chest pain to the emergency department: a comparison between cardiac and non-cardiac origin

The Journal of Emergency Medicine
Cenker EkenYildiray Cete

Abstract

The aim of this study was to determine the prevalence of anxiety and depressive disorders in patients presenting with chest pain to the Emergency Department (ED) and determine if there is a relationship between these and cardiac vs. non-cardiac chest pain. This prospective cross-sectional study was performed in an urban tertiary care hospital between March and October 2005. Consecutive patients presenting with chest pain were enrolled in the study. The prevalence of anxiety and depressive disorders in patients with chest pain were determined by using the Hospital Anxiety and Depression Scale. A total of 324 patients presented to the ED with chest pain during the study period. The mean age of the patients studied was 50.5 +/- 14 years; 67% were men and 33% were women. Of the 324 study patients, 194 (59.9%) patients were diagnosed with non-cardiac chest pain, 16 (4.9%) with stable angina, 84 (25.9%) with unstable angina, and 30 (9.3%) with acute myocardial infarction. No statistically significant differences were determined between patients with cardiac and non-cardiac chest pain both for anxiety (40% vs. 38.1%, respectively; p = 0.737) and depressive disorders (52.3% vs. 52.1%, respectively; p = 0.965). Anxiety and depressive di...Continue Reading

References

Jan 1, 1991·International Journal of Psychiatry in Medicine·L R WulsinJ R Hillard
Jan 1, 1988·International Journal of Psychiatry in Medicine·L R WulsinG W Rouan
Feb 15, 1995·Circulation·N Frasure-SmithM Talajic
Feb 1, 1995·Archives of Family Medicine·G E Simon, M VonKorff
Mar 4, 1998·Journal of Psychosomatic Research·R P FleetB D Beitman
Mar 20, 1998·General Hospital Psychiatry·H G Koenig
Feb 19, 1999·Psychosomatic Medicine·N Frasure-SmithM G Bourassa
May 16, 2000·Archives of Internal Medicine·F LespéranceP Théroux
May 17, 2001·International Clinical Psychopharmacology·H U WittchenW Meister
May 26, 2001·Diabetes Care·R J AndersonP J Lustman
Feb 8, 2002·Journal of Psychosomatic Research·Ingvar BjellandDag Neckelmann
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Dec 4, 2003·Journal of the American College of Cardiology·Jacqueline J M H StrikAdriaan Honig
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Aug 18, 2005·Journal of Cardiac Failure·Varda KonstamMarla J De Jong
Jan 28, 2006·Emergency Medicine Journal : EMJ·N S DemiryoguranO F Demir
Mar 15, 2008·Critical Pathways in Cardiology·Eugene Braunwald

❮ Previous
Next ❯

Citations

May 9, 2012·Vascular Health and Risk Management·Stewart A ShankmanMladen I Vidovich
May 24, 2011·Journal of Neurogastroenterology and Motility·Ronnie Fass, Sami R Achem
Jul 19, 2011·The Journal of Emergency Medicine·Nancy Lutwak, Curt Dill
Feb 6, 2013·Journal of Psychiatric and Mental Health Nursing·J E SannerM Udtha
Jun 14, 2014·Journal of Immigrant and Minority Health·Tam Truong DonnellySarah Omar
Oct 29, 2013·Psychology & Health·Loes SmeijersWillem J Kop
Mar 12, 2013·Psychology, Health & Medicine·Beate MuschallaMichael Linden
Aug 16, 2016·International Journal of Cardiology·Kirstine Roll VestergaardKasper K Iversen
Jul 7, 2020·Journal of Caring Sciences·Seyyedeh Halimeh KamaliZahra Razaghi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.